Acrivon Therapeutics, Inc. SEC filings

Filings

1. 4Acrivon Therapeutics, Inc.ACRVOct 8

   Acrivon Therapeutics reports stock sale

   • Mary Miller sold 294 shares on 10/05/2026
   • Price per share was $1.99
   • Proceeds allocated to employees

   Mary Miller, reporting

2. 4Acrivon Therapeutics, Inc.ACRVSep 2

   2 insider filings

   Michaela Levin, insider filing for ACRV

   Show all 2

   • 4Insider filing for ACRVSep 2
   • 3New insider at ACRVSep 2

   Michaela Levin, reporting

3. 4Acrivon Therapeutics, Inc.ACRVAug 27

   Peter Blume-Jensen, insider filing for ACRV

   Peter Blume-Jensen, reporting · Kristina Masson, reporting

4. 144Acrivon Therapeutics, Inc.ACRVAug 25

   Peter Blume-Jensen, planned sale of ACRV shares

   Peter Blume-Jensen, reporting

5. 4Acrivon Therapeutics, Inc.ACRVAug 20

   5 insider filings

   Katharine Peterson, insider filing for ACRV

   Show all 5

   • 4Insider filing for ACRVAug 20
   • 4Insider filing for ACRVAug 20
   • 4Insider filing for ACRVAug 20
   • 4Insider filing for ACRVAug 20
   • 4Insider filing for ACRVAug 20

   Katharine Peterson, reporting

6. SCHEDULE 13G/AAcrivon Therapeutics, Inc.ACRVAug 13

   Ownership stake disclosure by Sands Capital Life Sciences Pulse Fund II, L.P. (amended)

   Sands Capital Life Sciences Pulse Fund II, L.P., filed by

7. S-8Acrivon Therapeutics, Inc.ACRVAug 12

   Employee stock plan registration

8. 8-KAcrivon Therapeutics, Inc.ACRVAug 12

   Current report

9. 10-QAcrivon Therapeutics, Inc.ACRVAug 12

   Quarterly report

10. 4Acrivon Therapeutics, Inc.ACRVAug 6

    Adam D. Levy, insider filing for ACRV

    Adam D. Levy, reporting

11. 4Acrivon Therapeutics, Inc.ACRVJul 23

    Mary Miller, insider filing for ACRV

    Mary Miller, reporting

12. 4Acrivon Therapeutics, Inc.ACRVJun 22

    7 insider filings

    RA Capital Healthcare Fund LP, insider filing for ACRV

    Show all 7

    • 4Insider filing for ACRVJun 22
    • 4Insider filing for ACRVJun 22
    • 4Insider filing for ACRVJun 22
    • 4Insider filing for ACRVJun 22
    • 4Insider filing for ACRVJun 22
    • 4Insider filing for ACRVJun 22
    • 4Insider filing for ACRVJun 22

    RA Capital Healthcare Fund LP, reporting · RA CAPITAL MANAGEMENT, L.P., reporting · +3 more

13. 8-KAcrivon Therapeutics, Inc.ACRVJun 17

    Current report

14. 4Acrivon Therapeutics, Inc.ACRVMay 26

    Peter Blume-Jensen, insider filing for ACRV

    Peter Blume-Jensen, reporting · Kristina Masson, reporting

15. DEFA14AAcrivon Therapeutics, Inc.ACRVMay 22

    Additional proxy materials

16. 4Acrivon Therapeutics, Inc.ACRVMay 20

    14 insider filings

    RA Capital Healthcare Fund LP, insider filing for ACRV

    Show all 14

    • 4Insider filing for ACRVMay 20
    • 4Insider filing for ACRVMay 20
    • 4Insider filing for ACRVMay 20
    • 4Insider filing for ACRVMay 20
    • 4Insider filing for ACRVMay 20
    • 4Insider filing for ACRVMay 20
    • 4Insider filing for ACRVMay 20
    • 4Insider filing for ACRVMay 20
    • 4Insider filing for ACRVMay 20
    • 4Insider filing for ACRVMay 20
    • 4Insider filing for ACRVMay 20
    • 4Insider filing for ACRVMay 20
    • 4Insider filing for ACRVMay 20
    • 4Insider filing for ACRVMay 20

    RA Capital Healthcare Fund LP, reporting · RA CAPITAL MANAGEMENT, L.P., reporting · +3 more

17. 4Acrivon Therapeutics, Inc.ACRVMay 18

    5 insider filings

    Katharine Peterson, insider filing for ACRV

    Show all 5

    • 4Insider filing for ACRVMay 18
    • 4Insider filing for ACRVMay 18
    • 4Insider filing for ACRVMay 18
    • 4Insider filing for ACRVMay 18
    • 4Insider filing for ACRVMay 18

    Katharine Peterson, reporting

18. SCHEDULE 13G/AAcrivon Therapeutics, Inc.ACRVMay 15

    Ownership stake disclosure by CITADEL ADVISORS LLC (amended)

    CITADEL ADVISORS LLC, filed by

19. 10-QAcrivon Therapeutics, Inc.ACRVMay 13

    Quarterly report

20. 8-KAcrivon Therapeutics, Inc.ACRVMay 13

    Current report

21. ARSAcrivon Therapeutics, Inc.ACRVApr 30

    Annual report to shareholders

22. DEFA14AAcrivon Therapeutics, Inc.ACRVApr 30

    Additional proxy materials

Older filings on EDGAR